KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $256.0 million.

  • Gilead Sciences' Interest Expenses rose 756.3% to $256.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 387.36%. This contributed to the annual value of $977.0 million for FY2024, which is 349.58% up from last year.
  • Gilead Sciences' Interest Expenses amounted to $256.0 million in Q3 2025, which was up 756.3% from $254.0 million recorded in Q2 2025.
  • Gilead Sciences' 5-year Interest Expenses high stood at $260.0 million for Q1 2025, and its period low was $226.0 million during Q4 2022.
  • Moreover, its 5-year median value for Interest Expenses was $242.0 million (2022), whereas its average is $243.6 million.
  • In the last 5 years, Gilead Sciences' Interest Expenses tumbled by 1086.14% in 2021 and then skyrocketed by 1150.44% in 2023.
  • Gilead Sciences' Interest Expenses (Quarter) stood at $238.0 million in 2021, then dropped by 5.04% to $226.0 million in 2022, then grew by 11.5% to $252.0 million in 2023, then fell by 1.19% to $249.0 million in 2024, then increased by 2.81% to $256.0 million in 2025.
  • Its Interest Expenses stands at $256.0 million for Q3 2025, versus $254.0 million for Q2 2025 and $260.0 million for Q1 2025.